Landmark gene therapy for hereditary blindness closes in on FDA approval – New Atlas
New Atlas |
Landmark gene therapy for hereditary blindness closes in on FDA approval
New Atlas Back in August, the FDA approved the first gene therapy for general use in the United States. That particular treatment, for cancer, was beset by controversy due to its exorbitant price tag and potential side effects. Now another gene therapy is on the … |
